Abstract | ETHNOPHARMACOLOGICAL RELEVANCE: AIM OF THE STUDY: MATERIALS AND METHODS: Primary screening on the glutamate-induced excitotoxicity cell model was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Fluorescent-activated cell sorting (FACS) was used to analyze the activation level of glutamate receptors and mitochondria membrane potential after treatment. Transcriptomics and proteomics analysis was performed to identify possible targets of pterosin B. The key pathways were enriched by the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis through the Database for Annotation, Visualization, and Integrated Discovery (DAVID). The core targets were visualized by a protein-protein interaction network using STRING. The mRNA and protein expressions were evaluated using real-time quantitative polymerase chain reaction (Q-PCR) and western blot, respectively. Immunocytochemistry was performed to monitor mitochondrial and apoptotic proteins. Cellular reactive oxygen species (ROS) were measured by ROS assay, and Ca2+ was stained with Fluo-4 AM to quantify intracellular Ca2+ levels. RESULTS: We found pterosin B from Pteris laeta Wall. ex Ettingsh. showed significant neuroprotective activity against glutamate excitotoxicity, enhancing cell viability from 43.8% to 105% (p-value: <0.0001). We demonstrated that pterosin B worked on the downstream signaling pathways of glutamate excitotoxicity rather than directly blocking the activation of glutamate receptors. Pterosin B restored mitochondria membrane potentials, alleviated intracellular calcium overload from 107.4% to 95.47% (p-value: 0.0006), eliminated cellular ROS by 36.55% (p-value: 0.0143), and partially secured cells from LPS-induced inflammation by increasing cell survival from 46.75% to 58.5% (p-value: 0.0114). Notably, pterosin B enhanced the expression of nuclear factor-erythroid factor 2-related factor 2 (NRF2) and heme oxygenase-1 (HO-1) by 2.86-fold (p-value: 0.0006) and 4.24-fold (p-value: 0.0012), and down-regulated Kelch-like ECH-associated protein 1 (KEAP1) expression by 2.5-fold (p-value: 0.0107), indicating that it possibly promotes mitochondrial biogenesis and mitophagy to maintain mitochondria quality control and homeostasis, and ultimately inhibits apoptotic cell death. CONCLUSIONS: Our work revealed that pterosin B protected cells from glutamate excitotoxicity by targeting the downstream mitochondrial signals, making it a valuable candidate for developing potential therapeutic agents in treating neurodegenerative diseases.
|
Authors | Aifang Cheng, Yan Zhang, Jin Sun, Duli Huang, Jordy Evan Sulaiman, Xin Huang, Long Wu, Wenkang Ye, Chuanhai Wu, Henry Lam, Yusheng Shi, Pei-Yuan Qian |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 308
Pg. 116308
(May 23 2023)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 36822346
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Reactive Oxygen Species
- pterosin B
- Kelch-Like ECH-Associated Protein 1
- Glutamic Acid
- pterosin
- NF-E2-Related Factor 2
- Sesquiterpenes
|
Topics |
- Reactive Oxygen Species
(metabolism)
- Kelch-Like ECH-Associated Protein 1
(metabolism)
- Glutamic Acid
(metabolism)
- Pteris
(metabolism)
- NF-E2-Related Factor 2
(metabolism)
- Sesquiterpenes
(pharmacology)
- Mitochondria
- Oxidative Stress
|